Zacks: Nextgen Healthcare Inc (NXGN) Receives Average Recommendation of “Hold” from Analysts

Shares of Nextgen Healthcare Inc (NASDAQ:NXGN) have been assigned an average broker rating score of 3.09 (Hold) from the fourteen analysts that cover the company, Zacks Investment Research reports. Four investment analysts have rated the stock with a strong sell recommendation, seven have given a hold recommendation and three have given a strong buy recommendation to the company. Nextgen Healthcare’s rating score has improved by 4% from three months ago as a result of a number of analysts’ ratings changes.

Analysts have set a twelve-month consensus price objective of $19.91 for the company and are anticipating that the company will post $0.19 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Nextgen Healthcare an industry rank of 178 out of 255 based on the ratings given to its competitors.

Large investors have recently modified their holdings of the company. Foundry Partners LLC bought a new position in shares of Nextgen Healthcare during the third quarter valued at about $3,534,000. Hanson & Doremus Investment Management bought a new position in shares of Nextgen Healthcare during the third quarter valued at about $208,000. Smith Graham & Co. Investment Advisors LP bought a new position in shares of Nextgen Healthcare during the third quarter valued at about $10,350,000. NJ State Employees Deferred Compensation Plan bought a new position in shares of Nextgen Healthcare during the third quarter valued at about $402,000. Finally, Louisiana State Employees Retirement System bought a new position in shares of Nextgen Healthcare during the third quarter valued at about $420,000. 69.18% of the stock is owned by hedge funds and other institutional investors.



Shares of NASDAQ:NXGN opened at $19.61 on Friday. The stock has a market cap of $1.18 billion, a PE ratio of 35.11, a PEG ratio of 3.58 and a beta of 0.60. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.13. Nextgen Healthcare has a 12 month low of $12.24 and a 12 month high of $23.73.

Nextgen Healthcare (NASDAQ:NXGN) last issued its quarterly earnings data on Tuesday, July 31st. The company reported $0.14 EPS for the quarter, meeting the consensus estimate of $0.14. The firm had revenue of $133.20 million during the quarter, compared to the consensus estimate of $132.71 million. Nextgen Healthcare had a net margin of 0.22% and a return on equity of 10.69%. On average, equities analysts anticipate that Nextgen Healthcare will post 0.6 earnings per share for the current year.

About Nextgen Healthcare

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

Further Reading: Should You Consider an Index Fund?

Get a free copy of the Zacks research report on Nextgen Healthcare (NXGN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply